menu
    • menu
    [{"orgOrder":0,"company":"Deva Holding AS","sponsor":"TNC Ilac Arastirma Gelistirme Danismanlik San. ve Tic. Ltd. Sti. | TC Erciyes University","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"TURKEY","productType":"Antibiotic","year":"2010","type":"Inapplicable","leadProduct":"Levofloxacin","moa":"Topoisomerase IV | DNA gyrase","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"Deva Holding AS","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Deva Holding AS \/ TNC Ilac Arastirma Gelistirme Danismanlik San. ve Tic. Ltd. Sti. | TC Erciyes University","highestDevelopmentStatusID":"10","companyTruncated":"Deva Holding AS \/ TNC Ilac Arastirma Gelistirme Danismanlik San. ve Tic. Ltd. Sti. | TC Erciyes University"}]

    Find Clinical Drug Pipeline Developments & Deals by Deva Holding AS

    Menu

    Deva Holding AS

    EVENTS

    • Webinars & Exhibitions

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Deva Holding AS

                            Turkey arrow
                            BioFit
                            Not Confirmed

                            Deva Holding AS

                            Turkey arrow
                            BioFit
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Levofloxacin

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase III

                            Sponsor : TNC Ilac Arastirma Gelistirme Danismanlik San. ve Tic. Ltd. Sti. | TC Erciyes University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy and Safety Evaluation of Levofloxacin Triple Therapy for Helicobacter Pylori Eradication

                            Details : Levofloxacin is a Antibiotic drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Helicobacter Infections.

                            Product Name : Undisclosed

                            Product Type : Antibiotic

                            Upfront Cash : Inapplicable

                            May 26, 2010

                            Lead Product(s) : Levofloxacin

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase III

                            Sponsor : TNC Ilac Arastirma Gelistirme Danismanlik San. ve Tic. Ltd. Sti. | TC Erciyes University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth